Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corporation (NYSE: DDD) generates a steady flow of news across healthcare, aerospace and defense, industrial manufacturing, software and capital markets. As a pioneer in additive manufacturing, the company regularly issues updates on new 3D printers, materials, software platforms and application-specific solutions, as well as regulatory milestones and strategic partnerships.
Recent announcements highlight growth initiatives in aerospace and defense, where 3D Systems reports strong momentum in production printing systems and custom metal parts, expansion of its Littleton, Colorado A&D Application Center of Excellence, and participation in U.S. Air Force–sponsored programs for next-generation metal printing technologies. The company also shares developments from its NAMI joint venture in Saudi Arabia, including agreements in energy, infrastructure inspection and collaborations with major defense contractors.
In healthcare, news items include FDA 510(k) clearance expanding indications for the VSP Orthopedics virtual surgical planning platform to skeletally mature adolescents, along with commentary on the role of personalized healthcare and patient-specific devices in the company’s Med Tech business. Product-focused releases cover new stereolithography solutions such as the SLA 825 Dual, investment casting tools like ArrayCast and Accura SbF, and jewelry-focused systems such as the MJP 300W Plus wax printer.
Investors will also find financial and corporate updates, including quarterly earnings releases, software strategy announcements involving 3D Sprint, Oqton MOS and 3DXpert, and transactions related to convertible notes and capital structure. This news page brings together these diverse updates so readers can follow how 3D Systems’ technologies, partnerships and financial decisions shape its role in additive manufacturing.
3D Systems (NYSE: DDD) is advancing digital dentistry with its NextDent® material portfolio, which addresses over 30 dental applications. The company's solutions focus on patient-specific devices for straightening, protecting, repairing, and replacing teeth. Their NextDent materials, compatible with NextDent 5100 and LCD1 printers, as well as other leading dental 3D printers, have received regulatory approvals across the US, Europe, and Asia.
The company's dental 'repair' market is projected to reach $150 million by 2029 in the US alone, representing one-third of the global market. Combined with other dental segments, the total US market opportunity is estimated at nearly $1 billion. Key materials include NextDent C&B MFH for crowns and bridges, and CROWNTEC™ through a partnership with Saremco Dental AG. 3D Systems' digital dentistry solutions have already served more than one million patients.
3D Systems (NYSE:DDD) has scheduled the release of its first quarter 2025 financial results after U.S. market hours on Monday, May 12, 2025.
The company will host a conference call and simultaneous webcast to discuss these results on Tuesday, May 13, 2025, at 8:30 a.m. Eastern Time. Investors and interested parties can participate through two channels:
- Webcast: Available at www.3dsystems.com/investor
- Telephone: Dial-in number 201-689-8345
A replay of the webcast will be made available approximately two hours after the conference call concludes, accessible through the company's investor relations website.
3D Systems (NYSE: DDD) has achieved a significant milestone in medical technology by enabling the world's first Medical Device Regulation (MDR)-compliant 3D-printed PEEK facial implant at the point-of-care. The breakthrough was accomplished in collaboration with the University Hospital Basel, Switzerland, where surgeons successfully implanted the device on March 18, 2025.
The implant was produced using VESTAKEEP® i4 3DF PEEK on 3D Systems' EXT 220 MED printer, which features cleanroom-based architecture and simplified post-processing workflows. Since its launch in August 2023, the EXT 220 MED has been used in over 80 successful cranial implant surgeries at partner hospitals.
The 3D-printed maxillofacial implant market is projected to grow from over $2 billion in 2024 to more than $4 billion by 2034. 3D Systems has already worked with surgeons to plan more than 150,000 patient-specific cases and manufacture over two million implants and instruments for 100+ CE-marked and FDA-cleared devices.
3D Systems (NYSE: DDD) unveils groundbreaking manufacturing solutions at RAPID+TCT 2025, introducing three key innovations:
- The Figure 4 135 3D printer with Figure 4 Tough 75C FR Black material, designed for high-mix, low-volume manufacturing, reducing costs significantly for precision applications
- A new module for EXT Titan Pellet printers that improves process efficiency up to 60% through enhanced part solidity optimization and print bed mapping
- The QuickCast Diamond build style for PSLA 270 technology, advancing investment casting pattern production
The Figure 4 135 solution targets industries requiring high precision with a process capability index of 1.33 or above. The new EXT Titan Pellet module, available in Q3 2025, reduces post-processing time by up to 50%. These innovations reflect 3D Systems' continued R&D investment and commitment to application-specific manufacturing solutions.
3D Systems (NYSE:DDD) has completed the sale of its Geomagic® software portfolio to Hexagon's Manufacturing Intelligence Division for $123 million, expecting net proceeds of approximately $100 million. The transaction strengthens the company's balance sheet and allows focus on core additive manufacturing software platforms.
The company will concentrate on advancing its key software solutions: 3D Sprint®, 3DXpert®, and Oqton Industrial Manufacturing OS. 3D Systems plans to enhance these platforms by leveraging artificial intelligence and automation to accelerate 3D printing adoption in high-volume production environments.
3D Systems (NYSE:DDD) reported full-year 2024 revenue of $440 million, meeting the lower end of guidance despite a $9 million Q4 revenue reduction due to accounting changes in their Regenerative Medicine program. Q4 revenue decreased 3% to $111 million year-over-year.
The company announced a new cost reduction initiative targeting over $50 million in incremental annualized savings through 2025 and first-half 2026. The upcoming sale of their Geomagic software platform for $123 million is expected to close in early April, strengthening their balance sheet which showed $171 million in cash as of December 31, 2024.
For 2025, 3D Systems forecasts revenue between $420-435 million, representing flat to modest organic growth excluding Geomagic. They aim to achieve break-even or positive adjusted-EBITDA by Q4 2025. The company saw improved Q4 industrial printer systems sales and healthy consumable sales, though 2024 was challenging due to weak customer capital spending.
3D Systems (NYSE:DDD) has scheduled the release of its fourth quarter and full year 2024 financial results after market close on Wednesday, March 26, 2025. The company will also provide guidance for 2025 during this announcement.
A conference call and simultaneous webcast to discuss these results will be held on Thursday, March 27, 2025, at 8:30 a.m. Eastern Time. Investors can participate via webcast at www.3dsystems.com/investor or by telephone at 201-689-8345. A replay of the webcast will be available approximately two hours after the conference call concludes.